9-Deaza-5′-noraristeromycin

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 15, 2003, Pages 3331-3334

  Tuncbilek, Meral ^a,b   Schneller, Stewart W ^a  

^a AUBURN UNIVERSITY   (United States)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

4 TERT BUTYLDIMETHYLSILYLOXYCYCLOPENT 2 EN 1 YLACETATE; 9 DEAZA 5' NORARISTEROMYCIN; ACETIC ACID DERIVATIVE; ADENOSINE; ARISTEROMYCIN; DRUG DERIVATIVE; NUCLEOSIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CHEMISTRY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG SCREENING; DRUG SYNTHESIS; HOST CELL; NONHUMAN; VACCINIA VIRUS;

EID: 0037678530     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00268-2     Document Type: Article

References (21)

1. Koga M., Schneller S.W. Tetrahedron Lett. 31:1990;5861.
2. For a leading reference, see Rajappan V.P., Schneller S.W., Williams S.L., Kern E.R. Bioorg. Med. Chem. 10:2002;883.
3. (a) Boyer S.J., Leahy J.W. J. Org. Chem. 62:1997;3976
4. (b) Mohar B., Kobe J. Nucleosides Nucleotides. 18:1999;443
5. (c) Kuang R., Ganguly A.K., Chan T.-M., Pramanik B.N., Blythin D.J., McPhail A.T., Saksena A.K. Tetrahedron Lett. 41:2000;9575.
6. (a) Zimmerman T.P., Deeprose R.D., Wolberg G., Stopford C.R., Duncan G.S., Miller W.H., Miller R.L., Lim M.I., Ren W.Y., Klein R.S. Biochem. Pharmacol. 32:1983;1211
7. (b) Namikoshi M., Carmichael W.W., Sakai R., Jares-Erijman W.W., Kaup A.M., Rinehart K.L. J. Am. Chem. Soc. 115:1993;2504.
8. (a) Chun B.K., Chu C.K. Tetrahedron Lett. 40:1999;3309
9. (b) Chun B.K., Song G.Y., Chu C.K. J. Org. Chem. 66:2001;4852.
10. (a) Paquette L.A., Heidelbaugh T.M. Org. Synth. 73:1995;44
11. (b) Basra S.K., Drew M.G.B., Mann J., Kane P.D. J. Chem. Soc., Perkin Trans. 1. 2000;3592.
12. Siddiqi S.M., Chen X., Schneller S.W. Nucleosides Nucleotides. 12:1993;267.
13. -) and 2, human cytomegalovirus, Epstein-Barr virus, varicella zoster virus, vaccinia virus, cowpox virus, West Nile virus, Sindbis virus, adenovirus type 1, measles, punta toro virus, rhinovirus type 2, Venezuelan equine encephalitis, yellow fever, and human immunodeficiency virus 1 and 2.
14. Host cells used in the assays: HEL, HeLa, Vero, HFF, CEM, A-549, CV-1, KB, MA-104, and MDCK.
15. Siddiqi S.M., Chen X., Rao J., Schneller S.W., Ikeda S., Snoeck R., Andrei G., Balzarini J., De Clercq E. J. Med. Chem. 38:1995;1035.
16. Seley K.L., Schneller S.W., Rattendi D., Bacchi C.J. J. Med. Chem. 40:1997;622.
17. De Clercq E. Nucleosides Nucleotides. 17:1998;625.
18. Cools M., De Clercq E. Biochem. Pharmacol. 38:1989;1061.
19. (a) Siddiqi S.M., Chen X., Schneller S.W., Ikeda S., Snoeck R., Andrei G., Balzarini J., De Clercq E. J. Med. Chem. 37:1994;551
20. (b) Seley K.L., Schneller S.W., Korba B. Nucleosides Nucleotides. 16:1997;2095.
21. Barnard D.L., Stowell V.D., Seley K.L., Hegde V.R., Das S.R., Rajappan V.P., Schneller S.W., Smee D.F., Sidwell R.W. Antiviral Chem. Chemother. 12:2001;241.